ac21 - john bridgewater: impact of the covid-19 pandemic on cholangiocarcinoma
Published 3 years ago • 182 plays • Length 12:07Download video MP4
Download video MP3
Similar videos
-
2:21
ac21 - john bridgewater - day 3 opening
-
8:33
ac21 - conference closing
-
37:32
clinical trials in cholangiocarcinoma:abc experience - dr. john bridgewater
-
9:15
ac21 - ellyn goodrich: patient perspective
-
12:37
ac21 - ardaman shergill: mapk pathway targeting in cholangiocarcinoma
-
14:18
ac21 - panel discussion: management of bile duct occlusion & patient led data initiatives
-
6:31
understanding cholangiocarcinoma
-
4:11
cholangiocarcinoma patient matt reidy's biomarker story
-
18:52
brcch | covid-19 – a systemic vasculo-inflammatory disease
-
16:09
ac21 - panel discussion: locoregional management of cholangiocarcinoma
-
11:54
ac21 - mitesh borad: international cholangiocarcinoma research network (icrn)
-
25:06
integrating genomic signals into clinical trial... - john bridgewater, ucl, uk (d3p14)
-
7:22
ac21 - gonzalo sapisochin: management of perihilar cholangiocarcinoma - surgical transplant
-
16:42
ac21 - juan valle: mgmt of urgent symptoms in cca patients with biliary stents/drains
-
10:59
ac21 - ryan fields: definition of perihilar cholangiocarcinoma
-
10:56
ac21 - christine kang: imaging of perihilar cholangiocarcinoma
-
12:33
ac21 - shubham pant: targeting her2 in biliary tract cancers
-
10:07
ac21 - arndt vogel: management of perihilar cholangiocarcinoma - medical oncology
-
13:25
ac21 - funda meric: advances in cholangiocarcinoma
-
10:35
ac21 - chaundra bishop: patient perspective
-
8:44
ac21 - sophia cornew: ciitizen's clinical trial finder
-
19:50
molecular profiling – its growing importance and how can uk and european cca patients access it?